O	0	1	[	[	(	O
O	1	8	Effects	Effect	NNS	B-NP
O	9	11	of	of	IN	B-PP
O	12	25	carcinostatic	carcinostatic	JJ	B-NP
O	26	32	agents	agent	NNS	I-NP
O	33	35	in	in	IN	B-PP
O	36	39	the	the	DT	B-NP
O	40	52	hematogenous	hematogenous	JJ	I-NP
O	53	63	metastasis	metastasis	NN	I-NP
O	64	66	of	of	IN	B-PP
B-Cancer	67	73	cancer	cancer	NN	B-NP
O	73	74	]	]	)	O
O	74	75	.	.	.	O

O	77	80	The	The	DT	B-NP
O	81	93	experimental	experimental	JJ	I-NP
O	94	101	studies	study	NNS	I-NP
O	102	104	in	in	FW	B-ADVP
O	105	110	vitro	vitro	FW	I-ADVP
O	111	114	and	and	CC	O
O	115	117	in	in	FW	B-ADVP
O	118	122	vivo	vivo	FW	I-ADVP
O	123	127	were	be	VBD	B-VP
O	128	137	performed	perform	VBN	I-VP
O	138	140	to	to	TO	I-VP
O	141	152	investigate	investigate	VB	I-VP
O	153	156	the	the	DT	B-NP
O	157	164	effects	effect	NNS	I-NP
O	165	167	of	of	IN	B-PP
O	168	181	carcinostatic	carcinostatic	JJ	B-NP
O	182	188	agents	agent	NNS	I-NP
O	189	191	in	in	IN	B-PP
O	192	195	the	the	DT	B-NP
O	196	204	adhesion	adhesion	NN	I-NP
O	205	207	of	of	IN	B-PP
B-Cell	208	214	cancer	cancer	NN	B-NP
I-Cell	215	220	cells	cell	NNS	I-NP
O	221	223	to	to	TO	B-PP
B-Cell	224	235	endothelial	endothelial	JJ	B-NP
I-Cell	236	241	cells	cell	NNS	I-NP
O	241	242	.	.	.	O

O	243	250	Certain	Certain	JJ	B-NP
O	251	264	carcinostatic	carcinostatic	JJ	I-NP
O	265	271	agents	agent	NNS	I-NP
O	272	278	induce	induce	VBP	B-VP
O	279	282	the	the	DT	B-NP
O	283	293	expression	expression	NN	I-NP
O	294	296	of	of	IN	B-PP
O	297	298	E	E	NN	B-NP
O	298	299	-	-	HYPH	B-NP
O	299	307	selectin	selectin	NN	I-NP
O	308	310	on	on	IN	B-PP
B-Cell	311	322	endothelial	endothelial	JJ	B-NP
I-Cell	323	328	cells	cell	NNS	I-NP
O	329	332	and	and	CC	O
O	333	340	enhance	enhance	VB	B-VP
O	341	344	the	the	DT	B-NP
O	345	355	expression	expression	NN	I-NP
O	356	358	of	of	IN	B-PP
O	359	371	carbohydrate	carbohydrate	NN	B-NP
O	372	379	ligands	ligand	NNS	I-NP
O	380	382	on	on	IN	B-PP
B-Cell	383	389	cancer	cancer	NN	B-NP
I-Cell	390	395	cells	cell	NNS	I-NP
O	395	396	.	.	.	O

O	397	409	Consequently	Consequently	RB	B-ADVP
O	409	410	,	,	,	O
O	411	420	increased	increase	VBN	B-NP
O	421	429	adhesion	adhesion	NN	I-NP
O	430	432	of	of	IN	B-PP
B-Cell	433	439	cancer	cancer	NN	B-NP
I-Cell	440	445	cells	cell	NNS	I-NP
O	446	448	to	to	TO	B-PP
B-Cell	449	460	endothelial	endothelial	JJ	B-NP
I-Cell	461	466	cells	cell	NNS	I-NP
O	467	470	was	be	VBD	B-VP
O	471	479	observed	observe	VBN	I-VP
O	480	482	by	by	IN	B-PP
O	483	486	the	the	DT	B-NP
O	487	496	treatment	treatment	NN	I-NP
O	497	499	of	of	IN	B-PP
O	500	513	carcinostatic	carcinostatic	JJ	B-NP
O	514	520	agents	agent	NNS	I-NP
O	520	521	.	.	.	O

O	522	524	In	In	IN	B-PP
O	525	528	the	the	DT	B-NP
B-Immaterial_anatomical_entity	529	534	trans	trans	AFX	I-NP
I-Immaterial_anatomical_entity	534	535	-	-	HYPH	I-NP
I-Immaterial_anatomical_entity	535	542	splenic	splenic	JJ	I-NP
B-Organ	543	550	hepatic	hepatic	JJ	I-NP
O	551	561	metastasis	metastasis	NN	I-NP
O	562	567	model	model	NN	I-NP
O	568	573	using	use	VBG	B-VP
O	574	578	nude	nude	JJ	B-NP
O	579	583	mice	mouse	NNS	I-NP
O	583	584	,	,	,	O
O	585	588	the	the	DT	B-NP
O	589	601	augmentation	augmentation	NN	I-NP
O	602	604	of	of	IN	B-PP
B-Cancer	605	611	cancer	cancer	NN	B-NP
O	612	622	metastasis	metastasis	NN	I-NP
O	623	626	was	be	VBD	B-VP
O	627	635	observed	observe	VBN	I-VP
O	636	638	by	by	IN	B-PP
O	639	642	the	the	DT	B-NP
O	643	652	treatment	treatment	NN	I-NP
O	653	655	of	of	IN	B-PP
O	656	669	carcinostatic	carcinostatic	JJ	B-NP
O	670	676	agents	agent	NNS	I-NP
O	676	677	.	.	.	O

O	678	682	From	From	IN	B-PP
O	683	686	the	the	DT	B-NP
O	687	692	above	above	JJ	I-NP
O	692	693	,	,	,	O
O	694	696	we	we	PRP	B-NP
O	697	706	concluded	conclude	VBD	B-VP
O	707	711	that	that	IN	B-SBAR
O	712	725	carcinostatic	carcinostatic	JJ	B-NP
O	726	732	agents	agent	NNS	I-NP
O	733	736	may	may	MD	B-VP
O	737	745	increase	increase	VB	I-VP
O	746	749	the	the	DT	B-NP
O	750	760	metastatic	metastatic	JJ	I-NP
O	761	768	ability	ability	NN	I-NP
O	769	771	of	of	IN	B-PP
B-Cell	772	778	cancer	cancer	NN	B-NP
I-Cell	779	784	cells	cell	NNS	I-NP
O	785	787	in	in	IN	B-PP
O	788	796	patients	patient	NNS	B-NP
O	797	801	with	with	IN	B-PP
B-Cancer	802	808	cancer	cancer	NN	B-NP
O	808	809	.	.	.	O

